Cue Biopharma (CUE) Market Capitalization (2018 - 2026)

Cue Biopharma has disclosed Market Capitalization across 9 years of filings, most recently posting $165.0 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 89.45% year-over-year to $165.0 million; the TTM figure through Jun 2026 stood at $165.0 million (down 89.45% YoY), while the FY2025 annual figure was $884.1 million, down 56.27% from the prior year.
• Market Capitalization came in at $165.0 million for Q2 2026 at Cue Biopharma, down from $884.1 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $5.0 billion in Q1 2022 to a low of $165.0 million in Q2 2026.
• Average Market Capitalization over 5 years is $2.6 billion, with a median of $2.4 billion recorded in 2022.
• Year-over-year, Market Capitalization jumped 81.23% in 2023 and tumbled 89.45% in 2026.
• Over 5 years, Market Capitalization stood at $3.0 billion in 2022, then increased by 22.68% to $3.7 billion in 2023, then tumbled by 45.94% to $2.0 billion in 2024, then tumbled by 56.27% to $884.1 million in 2025, then sank by 81.33% to $165.0 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $165.0 million in Q2 2026, $884.1 million in Q4 2025, and $2.2 billion in Q3 2025.